Image analysis-derived metrics of histomorphological complexity predicts prognosis and treatment response in stage II-III colon cancer

被引:20
作者
Mezheyeuski, Artur [1 ,2 ]
Hrynchyk, Ina [3 ]
Karlberg, Mia [1 ]
Portyanko, Anna [2 ]
Egevad, Lars [1 ]
Ragnhammar, Peter [1 ]
Edler, David [4 ]
Glimelius, Bengt [5 ]
Ostman, Arne [1 ]
机构
[1] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden
[2] Belarusian State Med Univ, Dept Pathol, Minsk, BELARUS
[3] City Clin Pathologoanat Bur, Minsk, BELARUS
[4] Karolinska Univ Hosp Solna, Dept Mol Med & Surg, Stockholm, Sweden
[5] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden
基金
瑞典研究理事会;
关键词
THYMIDYLATE SYNTHASE EXPRESSION; COLORECTAL-CANCER; ADJUVANT THERAPY; MISMATCH REPAIR; FLUOROURACIL; CHEMOTHERAPY; INTERFACE; PATTERN; BENEFIT; MARKER;
D O I
10.1038/srep36149
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The complexity of tumor histomorphology reflects underlying tumor biology impacting on natural course and response to treatment. This study presents a method of computer-aided analysis of tissue sections, relying on multifractal (MF) analyses, of cytokeratin-stained tumor sections which quantitatively evaluates of the morphological complexity of the tumor-stroma interface. This approach was applied to colon cancer collection, from an adjuvant treatment randomized study. Metrics obtained with the method acted as independent markers for natural course of the disease, and for benefit of adjuvant treatment. Comparative analyses demonstrated that MF metrics out-performed standard histomorphological features such as tumor grade, budding and configuration of invasive front. Notably, the MF analyses-derived "alpha(max)" -metric constitutes the first response-predictive biomarker in stage II-III colon cancer showing significant interactions with treatment in analyses using a randomized trial-derived study population. Based on these results the method appears as an attractive and easy-to-implement tool for biomarker identification.
引用
收藏
页数:9
相关论文
共 30 条
[1]   Digital pattern recognition-based image analysis quantifies immune infiltrates in distinct tissue regions of colorectal cancer and identifies a metastatic phenotype [J].
Angell, H. K. ;
Gray, N. ;
Womack, C. ;
Pritchard, D. I. ;
Wilkinson, R. W. ;
Cumberbatch, M. .
BRITISH JOURNAL OF CANCER, 2013, 109 (06) :1618-1624
[2]   Systematic Analysis of Breast Cancer Morphology Uncovers Stromal Features Associated with Survival [J].
Beck, Andrew H. ;
Sangoi, Ankur R. ;
Leung, Samuel ;
Marinelli, Robert J. ;
Nielsen, Torsten O. ;
van de Vijver, Marc J. ;
West, Robert B. ;
van de Rijn, Matt ;
Koller, Daphne .
SCIENCE TRANSLATIONAL MEDICINE, 2011, 3 (108)
[3]   American society of clinical oncology recommendations on adjuvant chemotherapy for stage II colon cancer [J].
Benson, AB ;
Schrag, D ;
Somerfield, MR ;
Cohen, AM ;
Figueredo, AT ;
Flynn, PJ ;
Krzyzanowska, MK ;
Maroun, J ;
McAllister, P ;
Van Cutsem, E ;
Brouwers, M ;
Charette, M ;
Haller, DG .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (16) :3408-3419
[4]   Microsatellite Instability Predicts Improved Response to Adjuvant Therapy With Irinotecan, Fluorouracil, and Leucovorin in Stage III Colon Cancer: Cancer and Leukemia Group B Protocol 89803 [J].
Bertagnolli, Monica M. ;
Niedzwiecki, Donna ;
Compton, Carolyn C. ;
Hahn, Hejin P. ;
Hall, Margaret ;
Damas, Beatrice ;
Jewell, Scott D. ;
Mayer, Robert J. ;
Goldberg, Richard M. ;
Saltz, Leonard B. ;
Warren, Robert S. ;
Redston, Mark .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (11) :1814-1821
[5]   Risk of recurrence in patients with colon cancer stage II and III: A systematic review and meta-analysis of recent literature [J].
Bockelman, Camilla ;
Engelmann, Bodil E. ;
Kaprio, Tuomas ;
Hansen, Torben F. ;
Glimelius, Bengt .
ACTA ONCOLOGICA, 2015, 54 (01) :5-16
[6]  
Compton C, 2000, CANCER-AM CANCER SOC, V88, P1739, DOI 10.1002/(SICI)1097-0142(20000401)88:7<1739::AID-CNCR30>3.0.CO
[7]  
2-T
[8]  
Compton CC, 2000, ARCH PATHOL LAB MED, V124, P979
[9]   Personalizing Colon Cancer Adjuvant Therapy: Selecting Optimal Treatments for Individual Patients [J].
Dienstmann, Rodrigo ;
Salazar, Ramon ;
Tabernero, Josep .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (16) :1787-+
[10]   Thymidylate synthase expression in colorectal cancer:: A prognostic and predictive marker of benefit from adjuvant fluorouracil-based chemotherapy [J].
Edler, D ;
Glimelius, B ;
Hallström, M ;
Jakobsen, A ;
Johnston, PG ;
Magnusson, I ;
Ragnhammar, P ;
Blomgren, H .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (07) :1721-1728